sp19 provenge twitter Provenge, the first immunotherapy drug to receive FDA approval for use in patients, had its origins decades ago in the lab of Edgar Engleman. Photo by Timothy Archibald /2019
Category: COVID-19 Runaway immune reactions cause long COVID breathing problems Researchers at Stanford Medicine have investigated the mechanism of pulmonary fibrosis caused by long COVID. Author Christopher VaughanPublished on March 17, 2023March 16, 2023
Category: Neurobiology ‘Cyclic sighing’ can help breathe away anxiety Stanford Medicine researchers showed that five minutes a day of breathing exercises can reduce overall anxiety and improve mood. Author Hadley LeggettPublished on February 9, 2023February 17, 2023